"Insights from Supreme Court Abortion Pill Arguments"

During Supreme Court arguments, a majority of the justices seemed inclined to reject a bid to limit access to abortion pills, expressing doubts about the plaintiffs' standing and the potential nationwide implications of the case. The case centers on changes made by the FDA in 2016 and 2021, which broadened access to the drug mifepristone, allowing telemedicine prescriptions and mail delivery. Justices questioned the plaintiffs' remedy of applying nationwide restrictions, expressing concerns about second-guessing the FDA's regulatory authority.